Thread by @Mike_Honey_

Here's the latest variant picture with a global scope, to early June.

The LP.8.1.*, NB.1.8.1 "Nimbus" and XFG.* "Stratus" variants are battling for dominance in an unclear picture.

#COVID19 #Global #NB_1_8_1 #Nimbus #XFG #Stratus
🧵

XFG.* "Stratus" seemed to have the best underlying momentum, until recently when samples from the US became less dominant.
🧵

Here are the trends across all the International Traveller samples. From that perspective, XFG.* "Stratus" is now dominant for the first time, at 43%.

This dataset (mostly arrivals in the US and Japan) is arguably more random, as it is not skewed by sequencing volumes.
🧵

Globally, the NB.1.8.1 "Nimbus" variant is showing a slowing growth advantage of 3.3% per day (25% per week) over the LP.8.1.* variant, with a crossover in late May.
🧵

Here are the leading countries reporting NB.1.8.1 "Nimbus". There seem to be 3 tracks:
- China, Hong Kong and Thailand are reporting a clean sweep
- Singapore and Australia show steady growth to around 50%
- growth in the US and Canada has been lower.
🧵

Globally, the XFG.* "Stratus" variant is showing a stronger growth advantage of 6.3% per day (45% per week) over the LP.8.1.* variant. That shows a crossover in early June.
🧵

Here are the leading countries reporting XFG.* "Stratus". It reached 77% in India, before falling to finish at 73%. It has also shown sustained growth to 39% in the US and 34% in Spain.
🧵

Report link:

🧵 endsmike-honey.github.io/covid-19-genom…